Diabetes & Metabolism Journal最新文献_第5页

Diabetes Fact Sheets in Korea 2024. 2024年韩国糖尿病概况

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 DOI: 10.4093/dmj.2024.0818.c1

Se Eun Park, Seung-Hyun Ko, Ji Yoon Kim, Kyuho Kim, Joon Ho Moon, Nam Hoon Kim, Kyung Do Han, Sung Hee Choi, Bong Soo Cha

引用次数: 0

Exploring the Lack of Physical Activity among Adolescents Worldwide. 探讨全球青少年缺乏体育活动的问题。

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 DOI: 10.4093/dmj.2025.0181

Dalmacito A Cordero

引用次数: 0

Effects of Pancreatitis and Type 2 Diabetes Mellitus on the Development of Pancreatic Cancer: A Nationwide Nested Case-Control Study (Diabetes Metab J 2025;49:252-63). 胰腺炎和2型糖尿病对胰腺癌发展的影响：一项全国性的巢式病例对照研究（Diabetes Metab, 2025;49:252-63）。

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 DOI: 10.4093/dmj.2025.0314

Young-Eun Kim, Min Heui Yu, Chung Mo Nam, Eun Seok Kang

引用次数: 0

Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis (Diabetes Metab J 2025;49:235-51). 1型糖尿病患者胰岛素自动输送系统的有效性和安全性：系统评价和荟萃分析[J]; 2015;49:235-51。

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 DOI: 10.4093/dmj.2025.0282

Wenqi Fan, Chao Deng, Zhiguang Zhou, Xia Li

引用次数: 0

Ras Guanine Nucleotide-Releasing Protein-4 Inhibits Erythropoietin Production in Diabetic Mice with Kidney Disease by Degrading HIF2A. Ras鸟嘌呤核苷酸释放蛋白-4通过降解HIF2A抑制糖尿病肾病小鼠红细胞生成素的产生

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 Epub Date: 2025-01-23 DOI: 10.4093/dmj.2024.0398

Junmei Wang, Shuai Huang, Li Zhang, Yixian He, Xian Shao, A-Shan-Jiang A-Ni-Wan, Yan Kong, Xuying Meng, Pei Yu, Saijun Zhou

{"title":"Ras Guanine Nucleotide-Releasing Protein-4 Inhibits Erythropoietin Production in Diabetic Mice with Kidney Disease by Degrading HIF2A.","authors":"Junmei Wang, Shuai Huang, Li Zhang, Yixian He, Xian Shao, A-Shan-Jiang A-Ni-Wan, Yan Kong, Xuying Meng, Pei Yu, Saijun Zhou","doi":"10.4093/dmj.2024.0398","DOIUrl":"10.4093/dmj.2024.0398","url":null,"abstract":"Backgruound: In acute and chronic renal inflammatory diseases, the activation of inflammatory cells is involved in the defect of erythropoietin (EPO) production. Ras guanine nucleotide-releasing protein-4 (RasGRP4) promotes renal inflammatory injury in type 2 diabetes mellitus (T2DM). Our study aimed to investigate the role and mechanism of RasGRP4 in the production of renal EPO in diabetes.Methods: The degree of tissue injury was observed by pathological staining. Inflammatory cell infiltration was analyzed by immunohistochemical staining. Serum EPO levels were detected by enzyme-linked immunosorbent assay, and EPO production and renal interstitial fibrosis were analyzed by immunofluorescence. Quantitative real-time polymerase chain reaction and Western blotting were used to detect the expression of key inflammatory factors and the activation of signaling pathways. In vitro, the interaction between peripheral blood mononuclear cells (PBMCs) and C3H10T1/2 cells was investigated via cell coculture experiments.Results: RasGRP4 decreased the expression of hypoxia-inducible factor 2-alpha (HIF2A) via the ubiquitination-proteasome degradation pathway and promoted myofibroblastic transformation by activating critical inflammatory pathways, consequently reducing the production of EPO in T2DM mice.Conclusion: RasGRP4 participates in the production of renal EPO in diabetic mice by affecting the secretion of proinflammatory cytokines in PBMCs, degrading HIF2A, and promoting the myofibroblastic transformation of C3H10T1/2 cells.","PeriodicalId":11153,"journal":{"name":"Diabetes & Metabolism Journal","volume":" ","pages":"421-435"},"PeriodicalIF":6.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143022419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study. α -生育酚负载脂质体降低雪旺细胞高糖诱导的氧化应激：一项概念验证研究。

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 Epub Date: 2025-02-05 DOI: 10.4093/dmj.2024.0489

Jee-In Heo, Mi Jeong Kim, Daehyun Kim, Jimin Seo, Joon Ho Moon, Sung Hee Choi, Hak Jong Lee, Tae Jung Oh

引用次数: 0

Pancreatitis, Type 2 Diabetes Mellitus, and Pancreatic Cancer (Diabetes Metab J 2025;49:252-63). 胰腺炎、2型糖尿病与胰腺癌的关系[J] .中华糖尿病杂志，2015;49(1):252-63。

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 DOI: 10.4093/dmj.2025.0237

Shih-Wei Lai, Kuan-Fu Liao

引用次数: 0

Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization. 基于机器学习、单细胞转录组分析和孟德尔随机化，揭示VCAN作为糖尿病肾病肾小管和肾小球潜在的共同诊断生物标志物。

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 Epub Date: 2025-01-24 DOI: 10.4093/dmj.2024.0233

Li Jiang, Jie Jian, Xulin Sai, Xiai Wu

{"title":"Revealing VCAN as a Potential Common Diagnostic Biomarker of Renal Tubules and Glomerulus in Diabetic Kidney Disease Based on Machine Learning, Single-Cell Transcriptome Analysis and Mendelian Randomization.","authors":"Li Jiang, Jie Jian, Xulin Sai, Xiai Wu","doi":"10.4093/dmj.2024.0233","DOIUrl":"10.4093/dmj.2024.0233","url":null,"abstract":"Backgruound: Diabetic kidney disease (DKD) is recognized as a significant complication of diabetes mellitus and categorized into glomerular DKDs and tubular DKDs, each governed by distinct pathological mechanisms and biomarkers.Methods: Through the identification of common features observed in glomerular and tubular lesions in DKD, numerous differentially expressed gene were identified by the machine learning, single-cell transcriptome and mendelian randomization.Results: The diagnostic markers versican (VCAN) was identified, offering supplementary options for clinical diagnosis. VCAN significantly highly expressed in glomerular parietal epithelial cell and proximal convoluted tubular cell. It was mainly involved in the up-regulation of immune genes and infiltration of immune cells like mast cell. Mendelian randomization analysis confirmed that serum VCAN protein levels were a risky factor for DKD, while there was no reverse association. It exhibited the good diagnostic potential for estimated glomerular filtration rate and proteinuria in DKD.Conclusion: VCAN showed the prospects into DKD pathology and clinical indicator.","PeriodicalId":11153,"journal":{"name":"Diabetes & Metabolism Journal","volume":" ","pages":"407-420"},"PeriodicalIF":6.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143028025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Addressing the Persistent Increase and Inequities in Metabolically Unhealthy Obesity: Toward an Understanding of Clinical Obesity. 解决代谢不健康肥胖的持续增长和不公平：对临床肥胖的理解。

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 DOI: 10.4093/dmj.2025.0306

Young Sang Lyu, Sang Yong Kim

引用次数: 0

SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application. 糖尿病肾病的SGLT2抑制剂和GLP-1受体激动剂：不断发展的证据和临床应用

IF 6.8 2区医学

Diabetes & Metabolism Journal Pub Date : 2025-05-01 DOI: 10.4093/dmj.2025.0220

Jae Hyun Bae

{"title":"SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application.","authors":"Jae Hyun Bae","doi":"10.4093/dmj.2025.0220","DOIUrl":"10.4093/dmj.2025.0220","url":null,"abstract":"Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and significantly increases cardiovascular risk and mortality. Despite conventional therapies, including renin-angiotensin-aldosterone system inhibitors, substantial residual risk remains. The emergence of sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists has reshaped DKD management. Beyond glycemic control, these agents provide distinct and complementary cardiorenal benefits through mechanisms such as hemodynamic modulation, anti-inflammatory effects, and metabolic adaptations. Landmark trials, including CREDENCE, DAPA-CKD, EMPA-KIDNEY, and FLOW, have demonstrated their efficacy in preserving kidney function and reducing adverse outcomes. SGLT2 inhibitors appear more effective in mitigating glomerular hyperfiltration and lowering heart failure risk, whereas GLP-1 receptor agonists are particularly beneficial in reducing albuminuria and atherosclerotic cardiovascular events. Although indirect comparisons suggest that SGLT2 inhibitors may offer greater protection against kidney function decline, direct head-to-head trials are lacking. Combination therapy holds promise, however further studies are needed to define optimal treatment strategies. This review synthesizes current evidence, evaluates comparative effectiveness, and outlines future directions in DKD management, emphasizing precision medicine approaches to enhance clinical outcomes. The integration of these therapies represents a paradigm shift in diabetes care, expanding treatment options for people with diabetes mellitus at risk of kidney failure.","PeriodicalId":11153,"journal":{"name":"Diabetes & Metabolism Journal","volume":"49 3","pages":"386-402"},"PeriodicalIF":6.8,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0